View Older Stories
-
Paulson & Co. Slashes Stake in BofA (BAC), Citigroup (C); Shows New Stakes in Mosaic (MOS) and News Corp (NWSA)
-
Cooperman's Omega Advisors Shows Lower Tech Exposure, Raises Bet on Consumer Electronic Sales
-
Notable Analyst Rating Changes 08/02: (SOHU) (IPG) (LVS) Upgraded; (WMT) (TEVA) (SLE) Downgraded
-
Ainslie's Maverick Capital Shows New Stakes In Goldman Sachs (GS) and Wells Fargo (WFC), Also Like Solar (TSL) (YGE)
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Paulson's Paulson & Co Shows New Stakes In Alpha Natural (ANR), Family Dollar (FDO), HP (HP); Raises Transocean (RIG) and Liquidates Pfizer (PFE)
-
Cooperman's Omega Advisors Shows New Stakes In BofA (BAC) and Verizon (VZ)
-
Notable Analyst Rating Changes 05/09: (BHI) (ETFC) (PEP) Upgraded; (SPLS) (MJN) (DRWI) Downgraded
-
Notable ETF Movers of the Day 05/02: (XLV) (UNG) (XLY) Higher; (SLV) (TAN) (SMH) Lower
-
Notable Analyst Rating Changes 04/19: (ZION) (NAV) (RBN) Upgraded; (GS) (ABAT) (CRU) Downgraded
-
Morning Movers 04/05: (NSM) (NVGN) (ISPH) (QCOR) Higher; (DGW) (LEDS) (MERU) Lower
-
Paulson's Paulson & Co. Reduces Citi (C) Exposure; Keeps Gold Level; Likes Tech (STX)(RIG)ABX)(JPM)
-
Active equity option families in first 90-minutes of trading according to Track Data are: C AAPL TEVA LVS
-
Teva Pharma (TEVA) Enters $1.5B Revolving Credit Facility
-
George Soros' 13F Shows New Stakes in Dendreon, Dow, Citi, Raised Stakes in Plains Exploration, Teva, Verizon, AT&T, Pfizer, JPMorgan
-
Citi Reiterates a 'Buy' Rating on Teva Pharmaceutical (TEVA); Adjusts Estimates
-
Notable Analyst Rating Changes 07/26: AONE, PTEN, WFR, BX Upgraded; SAFM, TEVA, SLB, STM Downgraded
-
Teva Pharma (TEVA) Comments on U.S. FDA Approval of Generic Lovenox; Says Pending ANDA is Approvable
-
Citi on Generic Pharmaceuticals: Multiple Compression Overdone
-
Citi reiterates a 'Buy' on Teva Pharmaceutical (TEVA); Generic Differin Launch Adds Additional Upside Pressure to Earnings
-
Notable Analyst Rating Changes 06/02: JOYG, JPM, MON, JBL Upgraded; CA, ARST, HI, EXC Downgraded
-
Citi Reiterates a 'Buy' on Teva Pharmaceutical (TEVA); Generic Yaz Launch Adds Upside Pressure to Earnings
-
Citi Maintains a 'Buy' on Teva Pharmaceutical (TEVA); Clinical/Regulatory Activity Picking Up
-
Citi Reiterates a 'Buy' on WPI, TEVA & MYL After Generic Approval of VALTREX
-
Goldman Sachs' Hedge Fund VIP List (CIT, CF, ACL, GILD, more...)
-
Citi Reiterates a 'Buy' on Teva & Watson Pharma After Canadian Approval of Generic Lipitor
-
Citi Isues 1Q10 Earnings Preview on Generic Pharmaceuticals -Outperformance Expected
-
Cantor Fitzgerald Raises Price Target on Compugen (CGEN) to $12 After 'Landmark Discovery'
-
Morning Movers 9/17: HYTM, IVAN, XNPT, RNN, BSTC, AMR, SOLF Higher; DARA, SNV, HW Lower
-
Citi Reiterates a 'Buy' on Teva Pharmaceutical (TEVA); Adjusts Estimates Through 2011
-
Citi Reiterates a 'Buy' Rating on Teva Pharmaceutical (TEVA)
-
David Moenning's Daily State of the Markets: 3/13
-
Morning Movers 12/17: Morgan Stanley (MS) Sink On Losses; Apple (AAPL) Lower On Jobs' Health Rumors
-
Citi Initiates Coverage on Teva Pharmaceutical (TEVA) with a Buy, Premier Generics Play Buffered by Brands & Barr
-
David Moenning's Daily State of the Markets: 12/17
-
David Moenning’s Daily State of the Markets: 11/06
-
David Moenning’s Daily State of the Markets: 07/29
-
Pre-Open Movers 7/18: Citigroup (C) Jumps On Smaller Loss; SemGroup Energy Partners, L.P. (SGLP) Sinks On Parent's Possible BK Filing
-
Pre-Open Movers: Office Depot (ODP) Lower On Outlook; Greenbrier (GBX) Up On Results
-
David Moenning's Daily State of the Markets: 7/8
-
David Moenning's Daily State of the Markets: 05/07
-
Notable Analyst Rating Changes 3/14: BA, XOM, EK Upgraded; WLP, BBD, TEVA Downgraded
-
Citi Downgrades Teva Pharmaceutical (TEVA) to Hold
-
Summary of Jana Partners 13F; New Stakes in AA, APC, BEAS, CNET, Ups Stake in YHOO
-
David Moenning's Daily State of the Markets: 2/12
-
Wyeth (WYE) Hits New 52-Week Low on Generic Protonix News
